Dianyuan Li

Prof. Dr. Dianyuan Li


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
JQJiawei Qiu
Jiawei Qiu
SLShoujun Li
Shoujun Li
JYJun Yan
Jun Yan
QWQiang Wang
Qiang Wang
YSYunhu Song
Yunhu Song
DLDianyuan Li
Dianyuan Li

29 August 2025 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
HZHuan Zhang
Huan Zhang
KFKedi Fan
Kedi Fan
SJShuanglong Jia
Shuanglong Jia
QGQianyi Gao
Qianyi Gao
ZZZhentao Zhang
Zhentao Zhang
XMXingbo Mo
Xingbo Mo

19 March 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
BDBaoluo Du
Baoluo Du
ZDZiqiang Dai
Ziqiang Dai
HWHuan Wang
Huan Wang
ZRZhipeng Ren
Zhipeng Ren
DLDianyuan Li
Dianyuan Li
Background: Cardiovascular diseases remain one of the leading causes of death worldwide. Given the limited self-repair capacity of cardiac tissue, cardiac tissue engineering (CTE) aims to develop strategies and materials for repairing or replacing damaged cardiac tissue by combining biology, medicine, and engineering. Indeed, CTE has made significant strides since the discovery of induced pluripotent stem cells (iPSCs) in 2006, including creating cardiac patches, organoids, and chip models derived from iPSCs, thus offering new strategies for treating cardiac diseases. Methods: A systematic search for relevant literature published between 2003 and 2024 was conducted in the PubMed and Web of Science databases using “Cardiac Tissue Engineering”, “3D Bioprinting”, “Scaffold in Tissue Engineering”, “Induced Pluripotent Stem Cells”, and “iPSCs” as keywords. Results: This systematic search using the abovementioned keywords identified relevant articles for inclusion in this review. The resulting literature indicated that CTE can offer innovative solutions for treating cardiac diseases when integrated with three-dimensional (3D) bioprinting and iPSC technology. Conclusions: Despite notable advances in the field of CTE, multiple challenges remain relating to 3D-bioprinted cardiac tissues. These include maintaining long-term cell viability, achieving precise cell distribution, tissue vascularization, material selection, and cost-effectiveness. Therefore, further research is needed to optimize printing techniques, develop more advanced bio-inks, explore larger-scale tissue constructs, and ensure the biosafety and functional fidelity of engineered cardiac tissues. Subsequently, future research efforts should focus on these areas to facilitate the clinical translation of CTE. Moreover, additional long-term animal models and preclinical studies should be conducted to ensure the biosafety and functionality of engineered cardiac tissues, thereby creating novel possibilities for treating patients with heart diseases.

11 May 2026 in Xenotransplantation
Verified
Journal Article
Open access
XWXianzhi Wang
Xianzhi Wang
XWXijie Wu
Xijie Wu
ZDZiqiang Dai
Ziqiang Dai
LYLicheng Yan
Licheng Yan
JYJie Yan
Jie Yan
DLDianyuan Li
Dianyuan Li
Objectives: This study aimed to investigate the functional recovery of an 8‐gene‐edited pig heart after orthotopic xenotransplantation, the characteristics of the recipient's immune responses, and the efficacy of postoperative complication management to provide comprehensive experimental evidence for the clinical translation of xenogeneic cardiac transplantation technology. Methods: On December 27, 2025, an orthotopic heart was xenotransplanted from an 8‐gene‐edited pig to a rhesus macaque using the biatrial anastomosis technique. Postoperatively, comprehensive vital sign monitoring, immunosuppressive therapy, and complication interventions were implemented. Donor organ cardiac function, recipient immune indicators, and survival status were evaluated within 30 days after transplantation. Results: The recipient macaque survived for more than 30 days postoperatively. The cardiac function of the donor heart gradually stabilized, with the ejection fraction increasing from 58% in the early postoperative phase to 66%. No hyperacute immune rejection occurred. Postoperative complications, including infection, pleural effusion, and blood pressure fluctuations, were effectively controlled with symptomatic treatment. Conclusions: An 8‐gene‐edited pig heart demonstrates good biocompatibility in xenogeneic cardiac transplantation. Standardized surgical procedures, precise immunosuppressive regimens, and comprehensive postoperative care can effectively ensure desirable transplantation outcomes. This study offers an important technical reference for clinical xenogeneic cardiac transplantation.

11 March 2024 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
HWHuan Wang
Huan Wang
JLJixiang Liang
Jixiang Liang
GZGen Zhang
Gen Zhang
DHDongsheng He
Dongsheng He
BDBaoluo Du
Baoluo Du
DLDianyuan Li
Dianyuan Li
Background: Multimodal imaging plays a crucial role in evaluating suspected cardiac tumours. In recent years, three-dimensional (3D) printing technology has continued to advance such that image-based 3D-printed models have been incorporated into the auxiliary diagnosis and treatment of cardiac tumour diseases. The purpose of this review is to analyze the existing literature on the application of 3D printing in cardiac tumour surgery to examine the current status of the application of this technology. Methods: By searching PubMed, Cochrane, Scopus and Google Scholar, as well as other resource databases, a completed review of the available literature was performed. Effect sizes from published studies were investigated, and results are presented concerning the use of 3D surgical planning in the management of cardiac tumours. Results: According to the reviewed literature, our study comes to the point that 3D printing is a valuable technique for planning surgery for cardiac tumours. As shown in the review report, Mucinous and sarcomatous tumours are the most commonly used tumours for 3D printing, magnetic resonance imaging (MRI) and computed tomography (CT) are the most commonly used technologies for preparing 3D printing models, the main printing technology is stereolithography, and the most used 3D modeling software is Mimics. The printing time and cost required for 3D printing are affected by factors such as the size of the type, complexity, the printed material and the 3D printing technology used. The reported research shows that 3D printing can understand the anatomy of complex tumour cases, virtual surgical simulation, as well as facilitate doctor-patient communication and clinical teaching. Conclusions: These results show that the development of 3D printing technology has brought more accurate and safe perioperative treatment options for patients with cardiac tumours. Therefore, 3D printing technology is expected to become a routine clinical diagnosis and treatment tool for cardiac tumours.

6 May 2026 in Xenotransplantation
Verified
Journal Article
Closed access
SLShangxuan Li
Shangxuan Li
DHDongsheng He
Dongsheng He
XWXianzhi Wang
Xianzhi Wang
GCGuanzheng Cui
Guanzheng Cui
ZDZiqiang Dai
Ziqiang Dai
DLDianyuan Li
Dianyuan Li